AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36379267 — intervention group
Group type: EXPERIMENTAL
Intervention: Working hours > 28 hours
Number of subjects: 383
Study 36379267 — intervention group
Group type: EXPERIMENTAL
Intervention: Irregular working times
Number of subjects: 383
Study 36379267 — intervention group
Group type: EXPERIMENTAL
Intervention: No/little freedom in performance tasks
Number of subjects: 383
Study 36379267 — intervention group
Group type: EXPERIMENTAL
Intervention: Requiring physical strength
Number of subjects: 383
Study 36379267 — intervention group
Group type: EXPERIMENTAL
Intervention: High physical workload
Number of subjects: 383
Study 36379267 — intervention group
Group type: EXPERIMENTAL
Intervention: No/little freedom in performing tasks
Number of subjects: 383
Study 36379267 — intervention group
Group type: EXPERIMENTAL
Intervention: Working conditions not in accordance with guidelines
Number of subjects: 383
Study 33944923 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial incentives for statin therapy adherence
Number of subjects: 636
Study 33944923 — intervention group
Group type: COMPARATOR
Intervention: Nonimprovement group
Number of subjects: 636
Study 33290171 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimodality surgical-based settings (tonsillectomy + neck dissection + radiotherapy)
Number of subjects: 4720
Study 33290171 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical-based treatments
Number of subjects: 4720
Study 33290171 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgically treated group (HPV-negative patients)
Number of subjects: 4720
Study 33290171 — intervention group
Group type: COMPARATOR
Intervention: HPV-positive patients
Number of subjects: 4720
Study 34784557 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 0
Study 34784557 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative hypotension
Number of subjects: 0
Study 35024638 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral and mindfulness-based stress reduction (COBMINDEX)
Number of subjects: 0
Study 35024638 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls (HCs)
Number of subjects: 0
Study 36236451 — intervention group
Group type: EXPERIMENTAL
Intervention: Super Kids Adventure (SUKIA)
Number of subjects: 24
Study 36236451 — intervention group
Group type: COMPARATOR
Intervention: Nintendo Switch (NINS)
Number of subjects: 24
Study 34628275 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal negative mood induction
Number of subjects: 86
Study 34628275 — intervention group
Group type: COMPARATOR
Intervention: General negative mood induction
Number of subjects: 86
Study 34628275 — intervention group
Group type: COMPARATOR
Intervention: Interpersonal neutral mood induction
Number of subjects: 86
Study 33124792 — intervention group
Group type: EXPERIMENTAL
Intervention: Element-based functional training (EBFT)
Number of subjects: 47
Study 33124792 — intervention group
Group type: EXPERIMENTAL
Intervention: Task-specific-based functional training (TSBFT)
Number of subjects: 47
Study 33124792 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 47
Study 33397438 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjusted multi-biomarker disease activity (MBDA) score
Number of subjects: 953
Study 33397438 — intervention group
Group type: COMPARATOR
Intervention: Conventional risk factors (seropositivity, DAS28-CRP, CRP, SJC, CDAI)
Number of subjects: 953
Study 33328259 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio taping with tension (KTT)
Number of subjects: 45
Study 33328259 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio taping without tension (KTNT)
Number of subjects: 45
Study 33328259 — intervention group
Group type: COMPARATOR
Intervention: Control group (attended a class on KOA)
Number of subjects: 45
Study 35143676 — intervention group
Group type: EXPERIMENTAL
Intervention: Access to electricity
Number of subjects: 122
Study 35143676 — intervention group
Group type: EXPERIMENTAL
Intervention: Poverty status
Number of subjects: 122
Study 35143676 — intervention group
Group type: COMPARATOR
Intervention: Objective sleep measures for mothers
Number of subjects: 122
Study 35143676 — intervention group
Group type: COMPARATOR
Intervention: Objective sleep measures for children
Number of subjects: 122
Study 33951213 — intervention group
Group type: EXPERIMENTAL
Intervention: MiSight® 1 day contact lens
Number of subjects: 0
Study 33951213 — intervention group
Group type: COMPARATOR
Intervention: Untreated progressing myopes (control)
Number of subjects: 0
Study 33951213 — intervention group
Group type: COMPARATOR
Intervention: Emmetropes (virtual cohorts)
Number of subjects: 0
Study 34051728 — intervention group
Group type: EXPERIMENTAL
Intervention: Performance-based financing scheme
Number of subjects: 0
Study 34051728 — intervention group
Group type: COMPARATOR
Intervention: Control (non-incentivized antenatal care)
Number of subjects: 0
Study 32449296 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation (rTMS) of the primary sensory cortex
Number of subjects: 36
Study 32449296 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral capsaicin
Number of subjects: 36
Study 32449296 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-pharyngeal electrical stimulation (IPES)
Number of subjects: 36
Study 32449296 — intervention group
Group type: COMPARATOR
Intervention: Sham intervention
Number of subjects: 36
Study 36079769 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutri-Score
Number of subjects: 1064
Study 36079769 — intervention group
Group type: COMPARATOR
Intervention: NutrInform
Number of subjects: 1064
Study 34270731 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentinoids
Number of subjects: 203
Study 34270731 — intervention group
Group type: COMPARATOR
Intervention: Opioids (use of >40 morphine milligram equivalent before implantation)
Number of subjects: 203
Study 32552383 — intervention group
Group type: EXPERIMENTAL
Intervention: Freezing of gait (FoG)
Number of subjects: 153
Study 32552383 — intervention group
Group type: EXPERIMENTAL
Intervention: Fear of falling (FoF) and anxiety
Number of subjects: 153
Study 35381867 — intervention group
Group type: EXPERIMENTAL
Intervention: Diuretics (DT)
Number of subjects: 60
Study 35381867 — intervention group
Group type: COMPARATOR
Intervention: Volume Expansion (VE)
Number of subjects: 60
Study 34715530 — intervention group
Group type: EXPERIMENTAL
Intervention: SENSE program (parent education and age‐appropriate, positive sensory interventions for parents to conduct with their infants every day of hospitalization)
Number of subjects: 70
Study 34715530 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 70
Study 32674237 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 g of red furu
Number of subjects: 23
Study 32674237 — intervention group
Group type: COMPARATOR
Intervention: 50 g of tofu
Number of subjects: 23
Study 35129441 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation at 6,000 IU/day (D6 group)
Number of subjects: 262
Study 35129441 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation at 200,000 IU/month (D200 group)
Number of subjects: 262
Study 35129441 — intervention group
Group type: COMPARATOR
Intervention: Comparison between D6 group and D200 group
Number of subjects: 262
Study 34732513 — intervention group
Group type: EXPERIMENTAL
Intervention: Participatory learning and action (PLA) groups scaled up by government frontline workers in Jharkhand, eastern India.
Number of subjects: 51949
Study 34732513 — intervention group
Group type: COMPARATOR
Intervention: Delayed intervention start (control group).
Number of subjects: 51949
Study 34732513 — intervention group
Group type: EXPERIMENTAL
Intervention: Participatory women's groups scaled up by the Indian public health system.
Number of subjects: 51949
Study 34477899 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Consultation (EC)
Number of subjects: 64
Study 34477899 — intervention group
Group type: COMPARATOR
Intervention: Standard Consultation (SC)
Number of subjects: 64
Study 34187384 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic pain neuroscience education (TPNE; n = 25)
Number of subjects: 75
Study 34187384 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual therapy (MT; n = 25)
Number of subjects: 75
Study 34187384 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal (MM; n = 25)
Number of subjects: 75
Study 35697087 — intervention group
Group type: EXPERIMENTAL
Intervention: Music intervention (listening to music at bedtime for 4 weeks)
Number of subjects: 112
Study 35697087 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 112
Study 33544990 — intervention group
Group type: EXPERIMENTAL
Intervention: O-R toothbrush (Oral-B iO)
Number of subjects: 110
Study 33544990 — intervention group
Group type: COMPARATOR
Intervention: Sonic brush (Philips Sonicare DiamondClean)
Number of subjects: 110
Study 32557298 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 34877731 — intervention group
Group type: EXPERIMENTAL
Intervention: ≥2 iMAP symptoms associated with 'mild-moderate' non-IgE-mediated CMA
Number of subjects: 1303
Study 34877731 — intervention group
Group type: EXPERIMENTAL
Intervention: ≥2 iMAP symptoms associated with 'severe' non-IgE-mediated CMA
Number of subjects: 1303
Study 34877731 — intervention group
Group type: COMPARATOR
Intervention: ≥2 mild-moderate symptoms
Number of subjects: 1303
Study 34877731 — intervention group
Group type: COMPARATOR
Intervention: ≥2 severe symptoms
Number of subjects: 1303
Study 34877731 — intervention group
Group type: COMPARATOR
Intervention: Mean monthly reporting of ≥2 mild-moderate symptoms
Number of subjects: 1303
Study 34877731 — intervention group
Group type: COMPARATOR
Intervention: Mean monthly reporting of ≥2 severe symptoms
Number of subjects: 1303
Study 33962809 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF) injection
Number of subjects: 24
Study 33962809 — intervention group
Group type: EXPERIMENTAL
Intervention: Piezocision
Number of subjects: 24
Study 33962809 — intervention group
Group type: COMPARATOR
Intervention: Control (contralateral sides)
Number of subjects: 24
Study 32640027 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebrolysin plus donepezil
Number of subjects: 0
Study 32640027 — intervention group
Group type: COMPARATOR
Intervention: Donepezil alone
Number of subjects: 0
Study 33837400 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored intervention
Number of subjects: 153
Study 33837400 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 153
Study 32252684 — intervention group
Group type: EXPERIMENTAL
Intervention: Capecitabine plus Bevacizumab (Cap+Bev)
Number of subjects: 77
Study 32252684 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus plus Exemestane (Eve+Exe)
Number of subjects: 77
Study 32252684 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm A (Cap+Bev first-line, Eve+Exe second-line)
Number of subjects: 77
Study 32252684 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm B (Eve+Exe first-line, Cap+Bev second-line)
Number of subjects: 77
Study 32252684 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of Life (QoL)
Number of subjects: 77
Study 35666507 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel online group-coaching program
Number of subjects: 0
Study 35666507 — intervention group
Group type: EXPERIMENTAL
Intervention: Better Together Physician Coaching
Number of subjects: 0
Study 34388396 — intervention group
Group type: EXPERIMENTAL
Intervention: Teclistamab (subcutaneous at 1500 μg/kg once per week after step-up doses of 60 μg/kg and 300 μg/kg)
Number of subjects: 157
Study 34388396 — intervention group
Group type: EXPERIMENTAL
Intervention: Teclistamab (subcutaneous at 1500 μg/kg once per week)
Number of subjects: 157
Study 32463701 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS
Number of subjects: 27
Study 32463701 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal tDCS
Number of subjects: 27
Study 32463701 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 27
Study 35781772 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicarbonate-rich mineral water
Number of subjects: 51
Study 35781772 — intervention group
Group type: COMPARATOR
Intervention: Plain water
Number of subjects: 51
Study 34755760 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrinogen concentrate (50 mg/kg)
Number of subjects: 32
Study 34755760 — intervention group
Group type: COMPARATOR
Intervention: Control group (no early fibrinogen replacement)
Number of subjects: 32
Study 33332582 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-week guided self-help mindfulness-based intervention (MBI)
Number of subjects: 144
Study 33332582 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment (wait-list control)
Number of subjects: 144
Study 32972265 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 80
Study 32972265 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 80
Study 33858504 — intervention group
Group type: EXPERIMENTAL
Intervention: SVF
Number of subjects: 20
Study 33858504 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 20
Study 32032256 — intervention group
Group type: EXPERIMENTAL
Intervention: MNV3 lesions distribution
Number of subjects: 78
Study 35681088 — intervention group
Group type: EXPERIMENTAL
Intervention: Endogenous IGF-1 levels
Number of subjects: 49
Study 33373969 — intervention group
Group type: EXPERIMENTAL
Intervention: Doramectin 200 μg/kg live weight (LW)
Number of subjects: 20
Study 33373969 — intervention group
Group type: COMPARATOR
Intervention: Saline solution 1 mL/50 kg LW (Control)
Number of subjects: 20
Study 32653895 — intervention group
Group type: EXPERIMENTAL
Intervention: D-cycloserine (DCS) 50 mg
Number of subjects: 20
Study 32653895 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 33715537 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated Messaging (AM)
Number of subjects: 50
Study 33715537 — intervention group
Group type: COMPARATOR
Intervention: Standard Care (SC)
Number of subjects: 50
Study 33319651 — intervention group
Group type: EXPERIMENTAL
Intervention: Progesterone treatment
Number of subjects: 0
Study 33319651 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34637336 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab plus low-dose ipilimumab
Number of subjects: 45
Study 34172591 — intervention group
Group type: EXPERIMENTAL
Intervention: THINK (n = 46)
Number of subjects: 76
Study 34172591 — intervention group
Group type: COMPARATOR
Intervention: CON (n = 30)
Number of subjects: 76
Study 33535224 — intervention group
Group type: EXPERIMENTAL
Intervention: Early insulin treatment in VLBW infants
Number of subjects: 105
Study 33535224 — intervention group
Group type: COMPARATOR
Intervention: Standard care in VLBW infants
Number of subjects: 105
Study 33535224 — intervention group
Group type: COMPARATOR
Intervention: Term AGA infants
Number of subjects: 105
Study 33535224 — intervention group
Group type: EXPERIMENTAL
Intervention: Total group of children
Number of subjects: 105
Study 36062524 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate postpartum contraceptive implants (IPI)
Number of subjects: 194
Study 36062524 — intervention group
Group type: COMPARATOR
Intervention: Non-IPI (alternative method or no contraception)
Number of subjects: 194
Study 32970162 — intervention group
Group type: EXPERIMENTAL
Intervention: Cystus® tea mouthwash solution
Number of subjects: 60
Study 32970162 — intervention group
Group type: COMPARATOR
Intervention: Sage tea mouthwash solution
Number of subjects: 60
Study 32634551 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT) 24 weeks, 3 days per week, moderate intensity
Number of subjects: 157
Study 32634551 — intervention group
Group type: COMPARATOR
Intervention: Control (CTL)
Number of subjects: 157
Study 35457579 — intervention group
Group type: EXPERIMENTAL
Intervention: Yogurt group (YGT-G) consuming a yogurt drink (9.3 g protein, 39 g CHO, 192 kcal) after IWT
Number of subjects: 103
Study 35457579 — intervention group
Group type: COMPARATOR
Intervention: Carbohydrate group (CHO-G) consuming jelly (45 g CHO, 180 kcal) after IWT
Number of subjects: 103
Study 32421603 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive Short-Term Dynamic Psychotherapy (ISTDP)
Number of subjects: 60
Study 32421603 — intervention group
Group type: COMPARATOR
Intervention: Community Mental Health Teams (CMHT)
Number of subjects: 60
Study 35775194 — intervention group
Group type: EXPERIMENTAL
Intervention: MPS1 Inhibitor (BAY 1217389) in combination with Paclitaxel
Number of subjects: 0
Study 35775194 — intervention group
Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study 32476258 — intervention group
Group type: EXPERIMENTAL
Intervention: COVID-19 treatment modalities in SOT patients
Number of subjects: 10
Study 35742385 — intervention group
Group type: EXPERIMENTAL
Intervention: Episodic Future Thinking (EFT)
Number of subjects: 0
Study 35742385 — intervention group
Group type: EXPERIMENTAL
Intervention: Episodic Future Thinking + Smoking-Related Illness (EFT + SRI)
Number of subjects: 0
Study 35742385 — intervention group
Group type: COMPARATOR
Intervention: Episodic Recent Thinking (ERT)
Number of subjects: 0
Study 35742385 — intervention group
Group type: COMPARATOR
Intervention: Episodic Recent Thinking + Smoking-Related Illness (ERT + SRI)
Number of subjects: 0
Study 35742385 — intervention group
Group type: EXPERIMENTAL
Intervention: EFT
Number of subjects: 0
Study 35742385 — intervention group
Group type: EXPERIMENTAL
Intervention: SRI
Number of subjects: 0
Study 32970811 — intervention group
Group type: EXPERIMENTAL
Intervention: Audit and feedback intervention group
Number of subjects: 1856
Study 32970811 — intervention group
Group type: COMPARATOR
Intervention: Control group (participation in a national registry)
Number of subjects: 1856
Study 32943290 — intervention group
Group type: EXPERIMENTAL
Intervention: In-person contact before SAH
Number of subjects: 50
Study 32943290 — intervention group
Group type: EXPERIMENTAL
Intervention: In-person contact during SAH
Number of subjects: 50
Study 32943290 — intervention group
Group type: EXPERIMENTAL
Intervention: In-person contact by SAH week 6
Number of subjects: 50
Study 32943290 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol consumption and in-person contacts
Number of subjects: 50
Study 33337294 — intervention group
Group type: EXPERIMENTAL
Intervention: Home automation (HA) training
Number of subjects: 40
Study 33337294 — intervention group
Group type: COMPARATOR
Intervention: Traditional training (Control Group)
Number of subjects: 40
Study 34499045 — intervention group
Group type: EXPERIMENTAL
Intervention: SmokeFree buddy app
Number of subjects: 162
Study 34499045 — intervention group
Group type: COMPARATOR
Intervention: Control group (self-monitoring)
Number of subjects: 162
Study 34499045 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 162
Study 34530484 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg ketamine
Number of subjects: 71
Study 34530484 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 mg/kg ketamine
Number of subjects: 71
Study 34530484 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 71
Study 33096985 — intervention group
Group type: EXPERIMENTAL
Intervention: Confirmed CHD diagnosis
Number of subjects: 249
Study 33096985 — intervention group
Group type: EXPERIMENTAL
Intervention: Correct MI diagnosis in patients with confirmed CHD
Number of subjects: 249
Study 33096985 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-complex CHD diagnosis
Number of subjects: 249
Study 33096985 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex CHD diagnosis
Number of subjects: 249
Study 33096985 — intervention group
Group type: EXPERIMENTAL
Intervention: Incorrect MI diagnoses
Number of subjects: 249
Study 36360973 — intervention group
Group type: EXPERIMENTAL
Intervention: SGC and SP combined intervention group
Number of subjects: 237
Study 36360973 — intervention group
Group type: EXPERIMENTAL
Intervention: SP intervention group
Number of subjects: 237
Study 36360973 — intervention group
Group type: COMPARATOR
Intervention: Regular practice group
Number of subjects: 237
Study 32757504 — intervention group
Group type: EXPERIMENTAL
Intervention: Individually uptitrated, high-dose baclofen (30-300 mg/d)
Number of subjects: 320
Study 32757504 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 320
Study 33742551 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.12 mg ranibizumab
Number of subjects: 20
Study 33742551 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.20 mg ranibizumab
Number of subjects: 20
Study 33742551 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 20
Study 33742551 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurodevelopmental assessment
Number of subjects: 20
Study 33722257 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral rehydration solution (ORS)
Number of subjects: 10
Study 33722257 — intervention group
Group type: COMPARATOR
Intervention: Spring water
Number of subjects: 10
Study 33019775 — intervention group
Group type: EXPERIMENTAL
Intervention: SPOTONE ML predictor
Number of subjects: 0
Study 33509350 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiovascular screening before transplant listing
Number of subjects: 0
Study 33509350 — intervention group
Group type: COMPARATOR
Intervention: Current protocols for cardiovascular workup
Number of subjects: 0
Study 32004317 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical decision rule (Feverkidstool) guiding antibiotic prescription, withholding antibiotics in children with a low or intermediate predicted risk of bacterial pneumonia (≤10%).
Number of subjects: 999
Study 32004317 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical decision rule (Feverkidstool) guiding antibiotic prescription.
Number of subjects: 999
Study 36030249 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg memantine
Number of subjects: 20
Study 36030249 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 36030249 — intervention group
Group type: COMPARATOR
Intervention: Memantine vs. Placebo
Number of subjects: 20
Study 33499551 — intervention group
Group type: COMPARATOR
Intervention: Novel detoxification method
Number of subjects: 32
Study 35367170 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose rivaroxaban (2.5 mg twice daily for 30 days) + Dual Antiplatelet Therapy (DAPT)
Number of subjects: 279
Study 35367170 — intervention group
Group type: COMPARATOR
Intervention: Only Dual Antiplatelet Therapy (DAPT)
Number of subjects: 279